首页 | 本学科首页   官方微博 | 高级检索  
     


Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies
Authors:Yasmin M. Abaza MD  Tapan M. Kadia MD  Elias J. Jabbour MD  Marina Y. Konopleva MD  PhD  Gautam Borthakur MD  Alessandra Ferrajoli MD  Zeev Estrov MD  William G. Wierda MD  PhD  Ana Alfonso MD  Toh Han Chong MD  Charles Chuah MD  Liang‐Piu Koh MD  Boon‐Cher Goh MD  Julie E. Chang MD  Daniel E. Durkes BS  Maria Cielo Foudray RN  Hagop M. Kantarjian MD  Xiao Qin Dong MS  Guillermo Garcia‐Manero MD
Affiliation:1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Division of Medical Oncology, National Cancer Centre Singapore, Singapore;3. Cancer and Stem Cell Biology Program, Duke‐National University of Singapore Graduate Medical School Singapore, Singapore General Hospital, Singapore;4. Department of Hematology and Oncology, National University Cancer Institute, National University Hospital, Singapore;5. Division of Hematology and Oncology, University of Wisconsin Paul B. Carbone Comprehensive Cancer Center, Madison, Wisconsin;6. MEI Pharma Inc, San Diego, California
Abstract:
Keywords:acetylation  epigenetic  histone  methylation  pracinostat
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号